Al-Attar A, Presnell SR, Peterson CA, Thomas DT, Lutz CT
Overall, exenatide presents a highly cost-effective alternative to other antidiabetic agents for individuals seeking optimal glycemic control along with weight management support
The addition underscores Ros strategy of positioning itself as a one-stop shop for obesity care, blending telehealth consultations, insurance navigation and pharmacy services
Clinical data were extracted from patient medical records
PT-141's MC1R binding affinity is 50-fold lower than its MC4R affinity, meaning the dose required to produce melanogenesis would far exceed the dose that causes intolerable MC4R-mediated side effects like nausea and blood pressure elevation
They are not approved for human or veterinary use, and are intended solely for experimental or research purposes